| h-debate-bcfe8fd4aa0 | FcRn Transport Pathway Enhancers | 0.00 | 0.55 | FCGRT | proposed | 2026-04-29 | SDA-2026-04-12-gap-debate-20260410-112908-13c403ee |
| h-debate-e0d69bf9bc4 | FcRn Expression Biomarker-Guided Dosing | 0.00 | 0.55 | FCGRT | proposed | 2026-04-29 | SDA-2026-04-12-gap-debate-20260410-112908-13c403ee |
| h-debate-37d724d61ea | Dual-Pathway BBB Transport Optimization | 0.00 | 0.55 | TFRC | proposed | 2026-04-29 | SDA-2026-04-12-gap-debate-20260410-112908-13c403ee |
| h-debate-187ca49da92 | Alternative Fc Engineering for BBB Specificity | 0.00 | 0.55 | FCGRT | proposed | 2026-04-29 | SDA-2026-04-12-gap-debate-20260410-112908-13c403ee |
| h-debate-7e76e916406 | Species-Optimized Preclinical Models | 0.00 | 0.55 | FCGRT | proposed | 2026-04-29 | SDA-2026-04-12-gap-debate-20260410-112908-13c403ee |
| h-debate-f676b157978 | Perinatal Epigenetic Reprogramming as AD Prevention | 0.00 | 0.55 | DNMT3A | proposed | 2026-04-29 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-debate-0a8683288e8 | Epigenetic Memory Erasure in Aged Microglia | 0.00 | 0.55 | DNMT1 | proposed | 2026-04-29 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-debate-35bb97dcd03 | Gut-Brain Axis Microglial Depriming Strategy | 0.00 | 0.55 | TLR4 | proposed | 2026-04-29 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-debate-336ed22589a | Synaptic-Microglial Interface Restoration | 0.00 | 0.55 | C1Q | proposed | 2026-04-29 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-debate-ffb8f8a629e | IGFBPL1-Mediated Microglial Homeostasis Reset Therapy | 0.00 | 0.55 | IGFBPL1 | proposed | 2026-04-29 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-debate-0bf4d4b39f8 | Temporal Processing Enhancement Hypothesis | 0.00 | 0.55 | PVALB | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222510-20260402 |
| h-debate-4a67c759233 | Cross-Modal Integration Hypothesis | 0.00 | 0.55 | MBP | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222510-20260402 |
| h-debate-92a6999ffba | Cognitive Load Optimization Hypothesis | 0.00 | 0.55 | GABRA1 | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222510-20260402 |
| h-debate-a4bd1cea341 | Semantic Network Enhancement Hypothesis | 0.00 | 0.55 | GRIN2B | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222510-20260402 |
| h-debate-b60813d08f8 | Dopaminergic Cognitive Enhancement Hypothesis | 0.00 | 0.55 | COMT | proposed | 2026-04-29 | SDA-2026-04-04-gap-debate-20260403-222510-20260402 |
| h-debate-75ecad310ed | Metabolic Reprogramming of SPP1-Activated Microglia | 0.00 | 0.55 | HK2 | proposed | 2026-04-29 | SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755 |
| h-debate-054eb313c10 | CD44-SPP1 Axis Precision Targeting | 0.00 | 0.55 | CD44 | proposed | 2026-04-29 | SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755 |
| h-debate-4a8adbe2ea0 | Complement-Independent SPP1 Signaling Disruption | 0.00 | 0.55 | RHOA | proposed | 2026-04-29 | SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755 |
| h-debate-8dcbfbea61f | SPP1-Integrin Competitive Inhibition | 0.00 | 0.55 | ITGAV | proposed | 2026-04-29 | SDA-2026-04-15-gap-pubmed-20260406-062118-e3613755 |
| h-debate-f1235f1ab16 | Circadian Metabolic Rhythm Restoration | 0.00 | 0.55 | NR1D1, CLOCK, BMAL1 | proposed | 2026-04-29 | SDA-2026-04-02-gap-v2-e1e1b7c3 |
| h-debate-78c124518c7 | Metabolic Compartmentalization Therapy | 0.00 | 0.55 | MCT2, regional metabolic enzymes | proposed | 2026-04-29 | SDA-2026-04-02-gap-v2-e1e1b7c3 |
| h-debate-0847d0d9d79 | Mitochondrial Biogenesis Rescue via PGC-1α Activation | 0.00 | 0.55 | PPARGC1A, mitochondrial transcription factors | proposed | 2026-04-29 | SDA-2026-04-02-gap-v2-e1e1b7c3 |
| h-debate-0d109cd2f85 | Astrocyte-Microglia Metabolic Cross-Talk Modulation | 0.00 | 0.55 | MCT1, MCT4, HMGCS2 | proposed | 2026-04-29 | SDA-2026-04-02-gap-v2-e1e1b7c3 |
| h-debate-a40973dd495 | Trained Immunity Metabolic Reset | 0.00 | 0.55 | HK2, PKM2, mevalonate pathway enzymes | proposed | 2026-04-29 | SDA-2026-04-02-gap-v2-e1e1b7c3 |
| h-debate-646d075352b | Iron-Metabolism-Inflammasome Axis Disruption | 0.00 | 0.55 | GPX4, ACSL4, NLRP3 | proposed | 2026-04-29 | SDA-2026-04-02-gap-v2-e1e1b7c3 |
| h-debate-c1907c4deeb | NETs-MMP-Wnt Axis Therapeutic Cascade | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-16-gap-bbb-tjp-20260416041707 |
| h-debate-f6af368e805 | Peripheral-to-Central Inflammatory Relay Disruption | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-16-gap-bbb-tjp-20260416041707 |
| h-debate-404ce754f7a | Temporal Cytokine Window Therapeutic Intervention | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-16-gap-bbb-tjp-20260416041707 |
| h-debate-eadd0fa5911 | PS Exposure is Cell-Type Context-Dependent Rather Than Pathway-Specific | 0.00 | 0.55 | PS-binding receptor complexes (MERTK, AXL, TIMD4) | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-100359-5f096b45 |
| h-debate-b1b2a430511 | PS Externalization Requires Tau Aggregation-Phase Transition | 0.00 | 0.55 | Tau liquid-liquid phase separation intermediates, membrane c | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-100359-5f096b45 |
| h-debate-634ae1543cc | Oxidative Stress-Induced PS Exposure is Bnip3-Dependent in Tauopathy | 0.00 | 0.55 | BNIP3, MFN2 (mitochondrial dynamics) | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-100359-5f096b45 |
| h-debate-31ffa65ca9f | Hyperphosphorylated Tau Inhibits PMCA Pumps, Causing Sustained PS Exposure | 0.00 | 0.55 | ATP2B1 (PMCA1), ATP2B4 (PMCA4), TMEM16F, XKR4 | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-100359-5f096b45 |
| h-debate-ca8623bb619 | Regional Vulnerability Reflects Microglial PS-Sensing Heterogeneity | 0.00 | 0.55 | CX3CR1, microglial PS receptors (MERTK, AXL), regional trans | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-100359-5f096b45 |
| h-debate-b2a3bf9e4bf | Caspase-3 Cleavage of Tau Creates PS-Targeting Specificity | 0.00 | 0.55 | CASP3, tau cleavage products (ΔD25, ΔD391) | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-100359-5f096b45 |
| h-debate-3f5d76326a6 | Dual-Signal Model: PS + Tau N-terminal Fragments Enable Selective Targeting | 0.00 | 0.55 | Tau N-terminal fragments (aa 1-150), PS externalization | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-100359-5f096b45 |
| h-debate-1324f7b68ee | Pioneer Factor-Mediated Stimulus Filtering | 0.00 | 0.55 | FOXA1, PU.1, GATA1 | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095952-12fad421 |
| h-debate-eb438fd7088 | Super-Enhancer Hierarchy Model | 0.00 | 0.55 | BRD4, MED1, enhancer RNAs (eRNAs) | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095952-12fad421 |
| h-debate-781bdec4451 | Bivalent Domain Resolution as Stimulus Decoder | 0.00 | 0.55 | KDM6B (JMJD3), EZH2, UTX, RNF20 | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095952-12fad421 |
| h-debate-a698da25763 | Phagocytic Receptor (CSF1R)-Mediated Uptake of Circadian-Modifying Peptides | 0.00 | 0.55 | CSF1R / PER2 | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-2162e92f50d | TREM2 Ligand-Conjugated Nanocarriers for Microglial Circadian Modulator Delivery | 0.00 | 0.55 | TREM2 receptor | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-715a4183702 | CX3CR1-Cre-Driven BMAL1 Deletion as Microglial Circadian Clock Ablation | 0.00 | 0.55 | BMAL1 (ARNTL) / CX3CR1 promoter | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-762aa36a168 | Microglial-Specific miR-132/212 Cluster Delivery to Modulate Circadian Gene Netw | 0.00 | 0.55 | miR-132 / REV-ERBα (NR1D1) | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-e79aa9df18f | Astrocyte-Microglia Circadian Coupling via Extracellular Vesicle Transport | 0.00 | 0.55 | PER2 / CRY1 / SIRT1 | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-798ab8caa6e | Microglial NLRP3 Inflammasome as Circadian-Specific Drug Target | 0.00 | 0.55 | NLRP3 inflammasome / BMAL1 | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-5522db93188 | P2Y12 Receptor-Mediated Phase Resetting of Circadian Inflammatory Rhythms | 0.00 | 0.55 | P2Y12 / BMAL1-CLOCK complex | proposed | 2026-04-29 | SDA-2026-04-10-gap-debate-20260410-095945-976d542d |
| h-debate-d5862b41ad6 | Bile Acid Signaling Disruption Cascade | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-c77ea962308 | Prevotellaceae as Dopamine Precursor Modulators | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-8dff48967c6 | Circadian Rhythm Disruption via Microbiome-Clock Axis | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-2af67e4bdf2 | Systemic Metabolic Reprogramming via Prevotellaceae Loss | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |
| h-debate-02154a51ed0 | Prevotellaceae-Mediated Enteric Nervous System Priming Theory | 0.00 | 0.55 | | proposed | 2026-04-29 | SDA-2026-04-11-gap-debate-20260410-111558-f9487fea |